GB894810A - Aqueous pharmaceutical solutions containing anti-inflammatory steroids - Google Patents
Aqueous pharmaceutical solutions containing anti-inflammatory steroidsInfo
- Publication number
- GB894810A GB894810A GB27189/60A GB2718960A GB894810A GB 894810 A GB894810 A GB 894810A GB 27189/60 A GB27189/60 A GB 27189/60A GB 2718960 A GB2718960 A GB 2718960A GB 894810 A GB894810 A GB 894810A
- Authority
- GB
- United Kingdom
- Prior art keywords
- saturated
- bonded
- double
- ketone
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
Steroids of the general formula <FORM:0894810/IV (b)/1> wherein the 1 : 2 position is saturated or double-bonded, X is a hydrogen or halogen atom, R is lower (C1-6) alkyl and Z is a divalent hydrocarbon radical of less than 10 carbon atoms may be prepared by treating a compound of general <FORM:0894810/IV (b)/2> formula <FORM:0894810/IV (b)/3> in which the 1 : 2 position may be saturated or double-bonded and X and R have the above stated meanings with a polycarboxylic acid anhydride, e.g. succinic, maleic or phthalic anhydride. Alternatively, they may be partially esterified with a polycarboxylic acid, e.g. oxalic, malonic, succinic, glutaric, maleic, malic, tartaric, citramalic, citric, oxalacetic, phthalic, isophthalic, or terephthalic acid. The intermediate compounds of formula II above may be prepared by treating a compound of the general formula <FORM:0894810/IV (b)/4> wherein the 1 : 2 position is saturated or double-bonded and X is a hydrogen or halogen atom with a ketone, e.g. acetone, methyl-ethyl ketone, diethyl ketone or ethylamyl ketone. Examples include preparations of sodium and ammonium hemi-ester salts.ALSO:Clear, stable, aqueous compositions comprise a polyoxyethylene sorbitan mono-oleate non-ionic surfactant and an anti-inflammatory steroid hormone of the 11b -hydroxy-16a ,17a -di - (C1-6 alkyl) - substituted - methylenedioxy-21 - carboxyacyloxy - 4 - pregnene - 3,20 - dione class, e.g. a compound which may be represented by the general formula <FORM:0894810/VI/1> wherein the 1 : 2 position is saturated or double-bonded, X is a hydrogen or halogen atom, R is lower (C1-6) alkyl and Z is a divalent hydrocarbon radical of less than 10 carbon atoms. The compositions may be in forms suitable for topical application, e.g. to the ears, eye, nose and throat and for parenteral administration. Optionally they may also contain other water-soluble drugs, e.g. antibacterial agents, antibiotics, e.g. neomycin sulphate, and sulpha drugs; conventional buffers, preservatives and isotonicizers.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US894810XA | 1959-10-05 | 1959-10-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB894810A true GB894810A (en) | 1962-04-26 |
Family
ID=22217888
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB27189/60A Expired GB894810A (en) | 1959-10-05 | 1960-08-05 | Aqueous pharmaceutical solutions containing anti-inflammatory steroids |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB894810A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4158055A (en) * | 1973-08-17 | 1979-06-12 | American Cyanamid Company | Administration of 16α,17α-cyclopentylidenedioxy-9α-fluor O-11β,21-dihydroxy-1,4-pregnadiene-3,20-dione 21-acetate |
EP2941437A4 (en) * | 2013-01-07 | 2016-08-17 | Aciex Therapeutics Inc | Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof |
-
1960
- 1960-08-05 GB GB27189/60A patent/GB894810A/en not_active Expired
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4158055A (en) * | 1973-08-17 | 1979-06-12 | American Cyanamid Company | Administration of 16α,17α-cyclopentylidenedioxy-9α-fluor O-11β,21-dihydroxy-1,4-pregnadiene-3,20-dione 21-acetate |
EP2941437A4 (en) * | 2013-01-07 | 2016-08-17 | Aciex Therapeutics Inc | Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1059188A (en) | Colour stable oxytetracycline compositions and process for preparing same | |
GB894810A (en) | Aqueous pharmaceutical solutions containing anti-inflammatory steroids | |
GB847570A (en) | Shampoo compositions | |
GB952972A (en) | Improvements in or relating to the production of tetracycline compounds | |
GB1043149A (en) | Novel steroidal oximino ethers and methods for their manufacture | |
US4868170A (en) | Steriod lotion formulation | |
US2880138A (en) | Anti-inflammatory steroid solutions | |
US3335055A (en) | More stable and more soluble tetracycline compositions suitable for parenteral use and method of preparing same | |
NO141394B (en) | PROCEDURE FOR PREPARING A CLEAR, STABLE DISSOLUTION OF A CORTICOSTEROID PHOSPHATE SALT AND NEOMYCINE SULPHATE | |
JPS6333327A (en) | Stabilized phenylephrine liquid agent | |
NO138808C (en) | ANALOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE PREGNANIC ACID DERIVATIVES | |
US2720482A (en) | Stabilized streptomycin solutions | |
GB761618A (en) | Steroid hormone compositions | |
GB1347598A (en) | Lincomycin derivatives and the manufacture thereof | |
GB802005A (en) | Improvements in or relating to 6-methyl steroid compounds | |
US2100054A (en) | Anesthetic tannate | |
DE1053734B (en) | Process for solubilizing and stabilizing tetracycline antibiotics | |
IE31885B1 (en) | Reduction of corticosteroid side effects | |
IE811604L (en) | 11-alpha-amino androstanes | |
DE2352910A1 (en) | Aqueous PHARMACEUTICAL COMPOSITION | |
GB1490476A (en) | 6-aminomethylated-3-oxygenated cholest-5-enes | |
GB1108758A (en) | Substituted-17ª‡-buta-1',3'-diynyl-steroids | |
GB889310A (en) | Improvements in or relating to steroid compounds | |
GB894040A (en) | Salts of kanamycin and therapeutic compositions containing the same | |
GB839376A (en) | Steroid compounds and their preparation |